DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $452,445 | -0.2% | 1,824 | -3.4% | 0.08% | -23.5% |
| Q2 2023 | $453,180 | -6.7% | 1,888 | -2.1% | 0.10% | -12.5% |
| Q1 2023 | $485,869 | -18.3% | 1,928 | -14.0% | 0.11% | -20.0% |
| Q4 2022 | $594,851 | -5.6% | 2,241 | -8.0% | 0.14% | -21.3% |
| Q3 2022 | $630,000 | +2.6% | 2,437 | +0.6% | 0.18% | +3.5% |
| Q2 2022 | $614,000 | -22.5% | 2,422 | -10.3% | 0.17% | -5.0% |
| Q1 2022 | $792,000 | +76.4% | 2,701 | +98.2% | 0.18% | +47.2% |
| Q4 2021 | $449,000 | +13.1% | 1,363 | +4.6% | 0.12% | +5.1% |
| Q3 2021 | $397,000 | +26.0% | 1,303 | +10.9% | 0.12% | +23.2% |
| Q2 2021 | $315,000 | +19.3% | 1,175 | +0.2% | 0.10% | +9.2% |
| Q1 2021 | $264,000 | +3.1% | 1,173 | +1.6% | 0.09% | -3.3% |
| Q4 2020 | $256,000 | +2.8% | 1,154 | 0.0% | 0.09% | -9.1% |
| Q3 2020 | $249,000 | +22.1% | 1,154 | 0.0% | 0.10% | -7.5% |
| Q2 2020 | $204,000 | -7.3% | 1,154 | -19.5% | 0.11% | +7.0% |
| Q4 2019 | $220,000 | -36.6% | 1,433 | -40.3% | 0.10% | -41.9% |
| Q3 2019 | $347,000 | -5.4% | 2,400 | -6.5% | 0.17% | -8.5% |
| Q2 2019 | $367,000 | +8.9% | 2,568 | +0.7% | 0.19% | +14.6% |
| Q1 2019 | $337,000 | +21.2% | 2,551 | -5.5% | 0.16% | -3.0% |
| Q4 2018 | $278,000 | – | 2,700 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |